| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Bio Green Med Solution, Inc.
13D/A
BGMS · 23254L876
|
20.6% |
11/13/2025
Event 11/12/2025
|
||||
|
Cyclacel Pharmaceuticals, Inc.
13D
CYCC · 23254L801
Amended
under CUSIP
23254L876
on 11/13/2025
|
70.0% |
3/4/2025
Event 2/26/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.